Interferon-inducible effector mechanisms in cell-autonomous immunity

Nature Reviews Immunology

Volumn 12, Issue 5, 2012, Pages 367-382

  MacMicking, John D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BACTERIAL PROTEIN; COAT PROTEIN; GUANOSINE TRIPHOSPHATASE; INTERFERON; INTERFERON INDUCIBLE EFFECTOR PROTEIN; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RNA DIRECTED DNA POLYMERASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; AUTOPHAGY; BACTERIAL INFECTION; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM; CELL KILLING; CELLULAR IMMUNITY; CROHN DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; GENOME; HEPATITIS B VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; INTERFERON INDUCTION; INTRACELLULAR BACTERIUM; INTRACELLULAR SPACE; LIFE CYCLE; LYSOSOME; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARASITE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTOZOON; REVIEW; RNA EDITING; RNA SYNTHESIS; TUBERCULOSIS; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; WART VIRUS;

ANIMALS; CELLS; HUMANS; INFECTION; INTERFERONS;

EID: 84860258296     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3210     Document Type: Review

References (165)

1. Jones, J. D. & Dangl, J. L. The plant immune system. Nature 444, 323-329 (2006). (Pubitemid 44764102)
2. Marathe, R., Guan, Z., Anandalakshmi, R., Zhao, H. & Dinesh-Kumar, S. P. Study of Arabidopsis thaliana resistome in response to cucumber mosaic virus infection using whole genome microarray. Plant Mol. Biol. 55, 501-520 (2004). (Pubitemid 40653980)
3. Beutler, B. et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24, 353-389 (2006).
4. Mascie-Taylor, C. G. & Karim, E. The burden of chronic disease. Science 302, 1921-1922 (2003). (Pubitemid 37523490)
5. Bezbradica, J. J. & Medzhitov, R. Integration of cytokine and heterologous receptor signaling pathways. Nature Immunol. 10, 333-339 (2009).
6. Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
7. Nathan, C. & Shiloh, M. U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl Acad. Sci. USA 97, 8841-8848 (2000). (Pubitemid 30626635)
8. Sadler, A. & Williams, B. R. G. Interferon-inducible antiviral effectors. Nature Rev. Immunol. 8, 559-568 (2008). (Pubitemid 351913674)
9. Flannagan, R. S., Cosío, G. & Grinstein, S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nature Rev. Microbiol. 7, 355-366 (2009).
10. Nathan, C. F., Murray, H. W., Weibe, M. E. & Rubin, B. Y. Identification of IFN-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670-689 (1983). (Pubitemid 13051337)
11. MacMicking, J. D. Macrophage activation and host defense. Cell Host Microbe 5, 1-3 (2009).
12. Hertzog, P., Forster, S. & Samarajiwa, S. Systems biology of interferon responses. J. Interferon Cytokine Res. 31, 5-11 (2011).
13. Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254 (2009).
14. Kumar, D. et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140, 731-743 (2010).
15. Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
16. Kim, B. H. et al. A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science 332, 717-721 (2011).
17. Krombach, F. et al. Cell size of alveolar macrophages: an interspecies comparison. Environ. Health Perspect. 105 (Suppl. 5), 1261-1263 (1997).
18. MacMicking, J. D. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 25, 601-609 (2004). (Pubitemid 39369737)
19. Martens, S. & Howard, J. The IFN-inducible GTPases. Annu. Rev. Immunol. 22, 558-598 (2006).
20. Kumar, Y. & Valdivia, R. H. Leading a sheltered life: intracellular pathogens and maintenance of vacuolar compartments. Cell Host Microbe 5, 593-601 (2009).
21. Tiwari, S., Choi, H. P., Matsuzawa, T., Pypaert, M. & MacMicking, J. D. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P2 and PtdIns(3,4, 5)P3 promotes immunity to mycobacteria. Nature Immunol. 10, 907-917 (2009).
22. MacMicking, J. D., Taylor, G. A. & McKinney, J. D. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302, 654-659 (2003). (Pubitemid 37310923)
23. Singh, S. B., Davis, A. S., Taylor, G. A. & Deretic, V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438-1441 (2006). (Pubitemid 44360272)
24. Thurston, T. L., Ryzhakov, G., Bloor, S., von Muhlinen, N. & Randow, F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nature Immunol. 10, 1215-1221 (2009).
25. Thurston, T. L., Wandel, M. P., von Muhlinen, N., Foeglein, A. & Randow, F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482, 414-418 (2012).
26. Nathan, C. & Ding, A. SnapShot: reactive oxygen intermediates (ROI). Cell 140, 952-952.e2 (2010).
27. Karupiah, G. et al. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445-1448 (1993). (Pubitemid 23334265)
28. Lambeth, J. D. NOX enzymes and the biology of reactive oxygen. Nature Rev. Immunol. 4, 181-189 (2004). (Pubitemid 38339084)
29. Fields, K. A. & Hackstadt, T. The chlamydial inclusion: escape from the endocytic pathway. Annu. Rev. Cell Dev. Biol. 18, 221-245 (2002). (Pubitemid 35387351)
30. Oliveira Gde, A., Lieberman, J. & Barillas-Mury, C. Epithelial nitration by a peroxidase/NOX5 system mediates mosquito antiplasmodial immunity. Science 335, 856-859 (2012).
31. Sonoda, J. et al. Nuclear receptor ERRα and coactivator PGC-1β are effectors of IFN-γ-induced host defense. Genes Dev. 21, 1909-1920 (2007). (Pubitemid 47204930)
32. West, A. P. et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472, 476-480 (2011).
33. Bustamente, J. et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nature Immunol. 12, 213-221 (2011).
34. Gardet, A. et al. LRRK2 is involved in the IFN-γ response and host response to pathogens. J. Immunol. 185, 5577-5585 (2010).
35. Moskwa, P. et al. A novel host defense system of airways is defective in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175, 174-183 (2007). (Pubitemid 46115089)
36. Botteauxa, A., Hosteb, C., Dumontb, J. E., Van Sandeb, J. & Allaouia, A. Potential role of Noxes in the protection of mucosae: H2O2 as a bacterial chemorepellant. Microbes Infect. 11, 537-544 (2009).
37. Gattas, M. V. et al. Oxidative epithelial host defense is regulated by infectious and inflammatory stimuli. Free Radic. Biol. Med. 47, 1450-1458 (2009).
38. Flores, M. V. et al. Dual oxidase in the intestinal epithelium of zebrafish larvae has antibacterial properties. Biochem. Biophys. Res. Commun. 400, 164-168 (2010).
39. MacMicking, J. D. et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650 (1995).
40. Pollock, J. D. et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genet. 9, 202-209 (1995).
41. Shiloh, M. U. et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10, 29-38 (1999). (Pubitemid 29077381)
42. Ng, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D. & McKinney, J. D. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52, 1291-1302 (2004). (Pubitemid 38746304)
43. Singh, R. et al. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322, 1392-1395 (2008). (Pubitemid 352775253)
44. Myers, J. T., Tsang, A. W. & Swanson, J. A. Localized reactive oxygen and nitrogen intermediates inhibit escape of Listeria monocytogenes from vacuoles in activated macrophages. J. Immunol. 171, 5447-5453 (2003). (Pubitemid 37432833)
45. Bagshaw, R. D., Mahuran, D. J. & Callahan, J. W. A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of this organelle. Mol. Cell. Proteomics 4, 133-143 (2005). (Pubitemid 40361176)
46. Trost, M. et al. The phagosomal proteome in interferon-γ-activated macrophages. Immunity 30, 143-154 (2009).
47. Wild, P. et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333, 228-233 (2011).
48. Mostowy, S. et al. p62 and NDP52 proteins target intracytosolic Shigella and Listeria to different autophagy pathways. J. Biol. Chem. 286, 26987-26995 (2011).
49. Cemma, M., Kim, P. K. & Brumell, J. H. The ubiquitin-binding adaptor proteins p62/SQSTM1 and NDP52 are recruited independently to bacteria-associated microdomains to target Salmonella to the autophagy pathway. Autophagy 7, 341-345 (2011).
50. Yoshikawa, Y. et al. Listeria monocytogenes ActA-mediated escape from autophagic recognition. Nature Cell Biol. 11, 1233-1240 (2009).
51. Shenoy, A. R. et al. Emerging themes in IFN-γ-induced macrophage immunity by the p47 and p65 GTPase families. Immunobiology 212, 771-784 (2008). (Pubitemid 350246255)
52. Coers, J. et al. Chlamydia muridarum evades growth restriction by the IFN-γ-inducible host resistance factor Irgb10. J. Immunol. 180, 6237-6245 (2008).
53. Al-Zeer, M. A., Al-Younes, H. M., Braun, P. R., Zerrahn, J. & Meyer, T. F. IFN-γ-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy. PLoS ONE 4, e4588 (2009).
54. Lapaquette, P., Glasser, A. L., Huett, A., Xavier, R. J. & Darfeuille-Michaud, A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell. Microbiol. 12, 99-113 (2010).
55. Nelson, D. E. et al. Chlamydial IFN-γ immune evasion is linked to host infection tropism. Proc. Natl Acad. Sci. USA 101, 10658-10663 (2005). (Pubitemid 41061610)
56. Bernstein-Hanley, I. et al. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc. Natl Acad. Sci. USA 103, 14092-14097 (2006). (Pubitemid 44452985)
57. Henry, S. C. et al. Impaired macrophage function underscores susceptibility to Salmonella in mice lacking Irgm1 (LRG-47). J. Immunol. 179, 6963-6972 (2007).
58. Miyairi, I. et al. The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J. Immunol. 179, 1814-1824 (2007).
59. Singh, S. B. et al. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nature Cell Biol. 12, 1154-1165 (2010).
60. Brest, P. et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nature Genet. 43, 242-245 (2011).
61. Lippmann, J. et al. Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice. Cell. Microbiol. 13, 1668-1682 (2011).
62. Hunn, J. P. et al. Regulatory interactions between IRG resistance GTPases in the cellular response to Toxoplasma gondii. EMBO J. 27, 2495-2509 (2008).
63. Khaminets, A. et al. Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell. Microbiol. 12, 939-961 (2010).
64. Cai, Q. & Sheng, Z.-H. Uncovering the role of Snapin in regulating autophagy-lysosomal function. Autophagy 7, 445-447 (2011).
65. Grιgoire, I. P. et al. IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog. 7, e1002422 (2011).
66. McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nature Genet. 40, 1107-1112 (2008).
67. Intemann, C. D. et al. Autophagy gene variant IRGM-261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog. 5, e1000577 (2009).
68. King, K. Y. et al. Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS ONE 6, e16317 (2011).
69. Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011).
70. Rupper, A. C. & Cardelli, J. A. Induction of guanylate binding protein 5 by gamma interferon increases susceptibility to Salmonella enterica serovar Typhimurium-induced pyroptosis in RAW 264.7 cells. Infect. Immun. 76, 2304-2315 (2008).
71. Tietzel, I., El-Haibi, C. & Carabeo, R. A. Human guanylate binding proteins potentiate the anti-Chlamydia effects of interferon-γ. PLoS ONE 4, e6499 (2009).
72. Modiano, N., Lu, Y. E. & Cresswell, P. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-γ-inducible cofactor. Proc. Natl Acad. Sci. USA 102, 8680-8685 (2005). (Pubitemid 40862795)
73. Britzen-Laurent, N. et al. Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner. PLoS ONE 5, e14246 (2010).
74. Nantais, D. E., Schwemmle, M., Stickney, J. T., Vestal, D. J. & Buss, J. E. Prenylation of an interferon-γ-induced GTP-binding protein: the human guanylate binding protein, huGBP1. J. Leukoc. Biol. 60, 423-431 (1996). (Pubitemid 26325625)
75. Traver, M. K. et al. Immunity-related GTPase M (Irgm) proteins influence the localization of guanylate-binding protein 2 (Gbp2) by modulating macroautophagy. J. Biol. Chem. 286, 30471-30480 (2011).
76. Virreira Winter, S. et al. Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it. PLoS ONE 6, e24434 (2011).
77. Alonso, S., Pethe, K., Russell, D. G. & Purdy, G. E. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl Acad. Sci. USA 104, 6031-6036 (2007). (Pubitemid 47175653)
78. Ponpuak, M. et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 32, 1-13 (2010).
79. Kim, J. Y. & Ozato, K. The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-κB activity. J. Immunol. 182, 2131-2140 (2009).
80. Korioth, F., Gieffers, C., Maul, G. G. & Frey, J. Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell Biol. 130, 1-13 (1995).
81. Lu, F. T. et al. Expression and function of galectin-3, a β-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147, 1016-1028 (1995).
82. Shahnazari, S. et al. A diacylglycerol-dependent signaling pathway contributes to regulation of antibacterial autophagy. Cell Host Microbe 8, 137-146 (2010).
83. Jabado, N. et al. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J. Exp. Med. 192, 1237-1248 (2000).
84. Nairz, M. et al. Interferon-γ limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 38, 1923-1936 (2008).
85. White, C., Lee, J., Kambe, T., Fritsche, K. & Petris, M. J. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J. Biol. Chem. 284, 33949-33956 (2009).
86. Wagner, D. et al. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J. Immunol. 174, 1491-1500 (2005).
87. Govoni, G., Gauthier, S., Billia, F., Iscove, N. N. & Gros, P. Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. J. Leukoc. Biol. 62, 277-286 (1997). (Pubitemid 27380800)
88. Zaharik, M. L. et al. The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and SitABCD are essential for virulence in an Nramp1G169 murine typhoid model. Infect. Immun. 72, 5522-5525 (2004). (Pubitemid 39223447)
89. Wagner, D. et al. Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp. Microbiology 151, 323-332 (2005). (Pubitemid 40207692)
90. Sibley, L. D. Invasion and intracellular survival of protozoan parasites. Immunol. Rev. 240, 72-91 (2011).
91. Diefenbach, A. et al. Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77-87 (1998). (Pubitemid 28097825)
92. Holscher, C. et al. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in γ-interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66, 1208-1215 (1998). (Pubitemid 28101166)
93. Mellouk, S. et al. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin. Infect. Immun. 62, 4043-4046 (1994). (Pubitemid 24264354)
94. Scharton-Kersten, T. M., Yap, G., Magram, J. & Sher, A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261-1273 (1997). (Pubitemid 27172907)
95. Collazo, C. M. et al. Inactivation of LRG-47 and IRG-47 reveals a family of interferon γ-inducible genes with essential, pathogen-specific roles in resistance to infection. J. Exp. Med. 194, 181-188 (2001).
96. Zhao, Y. et al. Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J. Immunol. 182, 3775-3781 (2009).
97. Halonen, S. K., Taylor, G. A. & Weiss, L. M. Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect. Immun. 69, 5573-5576 (2001). (Pubitemid 32786493)
98. Martens, S. et al. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 1, e24 (2005).
99. Ling, Y. M. et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp. Med. 203, 2063-2071 (2006).
100. Zhao, Y., Wilson, D., Matthews, S. & Yap, G. S. Rapid elimination of Toxoplasma gondii by gamma interferon-primed mouse macrophages is independent of CD40 signaling. Infect. Immun. 75, 4799-4803 (2007). (Pubitemid 47502149)
101. Liesenfeld, O. et al. The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS ONE 6, e20568 (2011).
102. Santiago, H. C. et al. Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth. J. Immunol. 175, 8165-8172 (2005). (Pubitemid 41798380)
103. Zhao, Z. et al. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4, 458-469 (2008).
104. Degrandi, D. et al. Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J. Immunol. 179, 7729-7740 (2007).
105. Fentress, S. J. et al. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8, 484-495 (2010).
106. Pfefferkorn, E. R. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl Acad. Sci. USA 81, 908-912 (1984). (Pubitemid 14197611)
107. Carlin, J. M., Borden, E. C. & Byrne, G. I. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J. Interferon Res. 9, 329-337 (1989). (Pubitemid 19168455)
108. Roshick, C., Wood, H., Caldwell, H. D. & McClarty, G. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect. Immun. 74, 225-238 (2006). (Pubitemid 43023077)
109. Daubener, W. et al. Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect. Immun. 69, 6527-6531 (2001). (Pubitemid 32885221)
110. Mao, R. et al. Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J. Virol. 85, 1048-1057 (2011).
111. Meisel, R. et al. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 25, 648-654 (2011).
112. Knubel, C. P. et al. Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi. FASEB J. 24, 2689-2701 (2010).
113. Divanovic, S. et al. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J. Infect. Dis. 205, 152-161 (2012).
114. Siegrist, F., Eberling, M. & Certa, U. The small interferon-induced transmembrane genes and proteins. J. Interferon Cytokine Res. 31, 183-197 (2011).
115. Lu, J. et al. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85, 2126-2137 (2011).
116. Huang, I. C. et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 7, e1001258 (2011).
117. Weidner, J. M. et al. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84, 12646-12657 (2010).
118. Yount, J. S. et al. Palmitoylome profiling reveals S-palmitoylation- dependent antiviral activity of IFITM3. Nature Chem. Biol. 6, 610-614 (2010).
119. Feeley, E. M. et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 7, e1002337 (2011).
120. McNab, F. W., Rasjbaum, R., Stoyle, J. P. & O'Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46-56 (2011).
121. Uchil, P. D., Quinlin, B. D., Chan, W.-T., Luna, J. M. & Mothes, W. TRIM E3 ligases interfere with the early and late stages of the retroviral life cycle. PLoS Pathog. 4, e16 (2008).
122. Stemlau, M. et al. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853 (2004).
123. Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365 (2011).
124. Gao, B., Duan, Z., Xu, W. & Xiong, S. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50, 424-433 (2009).
125. Eldin, P. et al. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J. Gen. Virol. 90, 536-545 (2009).
126. Taylor, R. T. et al. TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10, 185-196 (2011).
127. Mallery, D. L. et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl Acad. Sci. USA 107, 19985-19990 (2010).
128. Haller, O. & Kochs, G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J. Interferon Cytokine Res. 31, 79-87 (2011).
129. Mordstein, M. et al. Interferon-a; contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4, e1000151 (2008).
130. Gao, S. et al. Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 465, 502-506 (2010).
131. Nordmann, A., Wixler, L., Boergeling, Y., Wixler, V. & Ludwig, S. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J. 26, 1290-1300 (2012).
132. Itsui, Y. et al. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50, 1527-1537 (2009).
133. Elde, N. C., Child, S. J., Geballe, A. P. & Malik, H. S. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457, 485-489 (2009).
134. Harris, R. S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809 (2003). (Pubitemid 36724943)
135. Mbisa, J. L., Bu, W. & Pathak, V. K. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms. J. Virol. 84, 5250-5259 (2010).
136. Laguette, N. et al. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657 (2011).
137. Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661 (2011).
138. Goldstone, D. C. et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480, 379-382 (2011).
139. Lenschow, D. J. et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl Acad. Sci. USA 104, 1371-1376 (2007). (Pubitemid 46184011)
140. Durfee, L. A., Lyon, N., Seo, K. & Huibregtse, J. M. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol. Cell 38, 722-732 (2010).
141. Skaug, B. & Chen Z. J. Emerging role of ISG15 in antiviral immunity. Cell 143, 187-190 (2010).
142. Bi, Z. & Reiss, C. S. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69, 2208-2213 (1995).
143. Mannick, J. B., Asano, K., Izumi, K., Kieff, E. & Stamler, J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus replication. Cell 79, 1137-1146 (1994).
144. Zaragoza, C. et al. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc. Natl Acad. Sci. USA 95, 2469-2474 (1998).
145. Neil, S. J. et al. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-431 (2008).
146. Van Damme, N. et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252 (2008). (Pubitemid 351494713)
147. Evans, D. T., Serrano-Moreno, R., Singh, R. K. & Guatelli, J. C. BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 18, 388-396 (2010).
148. Perez-Caballero, D. et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499-511 (2009).
149. Hinz, A. et al. Structural basis of HIV-1 tethering to membranes by the BST-2/Tetherin ectodomain. Cell Host Microbe 7, 314-323 (2010).
150. Seo, J. Y., Yaneva, R. & Cresswell, P. Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe 10, 534-539 (2011).
151. Hinson, E. R. & Cresswell, P. The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic helix. Proc. Natl Acad. Sci. USA 106, 20452-20457 (2009).
152. Wang, X., Hinson, E. R. & Cresswell, P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2, 96-105 (2007). (Pubitemid 47209520)
153. Stzretter, K. J. et al. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J. Virol. 85, 11557-11566 (2011).
154. Shapira, S. D. & Hacohen, N. Systems biology approaches to dissect mammalian innate immunity. Curr. Opin. Immunol. 23, 71-77 (2011).
155. Amit, I., Regev, A. & Hacohen, N. Strategies to discover regulatory circuits of the mammalian immune system. Nature Rev. Immunol. 11, 873-880 (2011).
156. Aderem, A. et al. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. mBio 2, 1-4 (2011).
157. Bierne, H. & Cossart, P. When bacteria target the nucleus: the emerging family of nucleomodulins. Cell. Microbiol. 23 Feb 2012 (doi: 10.1111/j.1462-5822.2012.01758.x).
158. Schnoor, M., Betanzos, A., Weber, D. A. & Parkos, C. A. Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-γ and regulates barrier function through effects on apoptosis. Mucosal Immunol. 2, 33-42 (2009).
159. Bonazzi, M. & Cossart, P. Impenetrable barriers or entry portals? The role of cell-cell adhesion during infection. J. Cell Biol. 195, 349-358 (2011).
160. Blanc, M. et al. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol. 9, e1000598 (2011).
161. Orvedahl, A. et al. Image-based genome-wide siRNA screen identifies selective autophagy factors. Nature 480, 113-117 (2011).
162. Pedersen, I. M. et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-923 (2007).
163. MacMicking, J. D. Immune control of phagosomal bacteria by p47 GTPases. Curr. Opin. Microbiol. 8, 74-82 (2005). (Pubitemid 40203229)
164. Gomez, L. M. et al. A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis 87, 288-294 (2008).
165. Li, X. L. et al. An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity. Proc. Natl Acad. Sci. USA 105, 20816-20821 (2008).